209 related articles for article (PubMed ID: 33923413)
1. Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses.
Mayor J; Torriani G; Engler O; Rothenberger S
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923413
[TBL] [Abstract][Full Text] [Related]
2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
3. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
4. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo activity of ribavirin against Andes virus infection.
Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
[TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Flow Cytometry Screen Identifies Molecules That Inhibit Hantavirus Cell Entry.
Buranda T; Gineste C; Wu Y; Bondu V; Perez D; Lake KR; Edwards BS; Sklar LA
SLAS Discov; 2018 Aug; 23(7):634-645. PubMed ID: 29608398
[TBL] [Abstract][Full Text] [Related]
7. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y
Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674
[TBL] [Abstract][Full Text] [Related]
8. A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines.
Yang Y; Cheng H; Yan H; Wang PZ; Rong R; Zhang YY; Zhang CB; Du RK; Rong LJ
J Med Virol; 2017 May; 89(5):908-916. PubMed ID: 27704591
[TBL] [Abstract][Full Text] [Related]
9. Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals.
Charrel RN; Coutard B; Baronti C; Canard B; Nougairede A; Frangeul A; Morin B; Jamal S; Schmidt CL; Hilgenfeld R; Klempa B; de Lamballerie X
Antiviral Res; 2011 May; 90(2):102-14. PubMed ID: 21356244
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small-molecule entry inhibitor for filoviruses.
Basu A; Li B; Mills DM; Panchal RG; Cardinale SC; Butler MM; Peet NP; Majgier-Baranowska H; Williams JD; Patel I; Moir DT; Bavari S; Ray R; Farzan MR; Rong L; Bowlin TL
J Virol; 2011 Apr; 85(7):3106-19. PubMed ID: 21270170
[TBL] [Abstract][Full Text] [Related]
11. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
[TBL] [Abstract][Full Text] [Related]
12. Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever.
Tang K; He S; Zhang X; Guo J; Chen Q; Yan F; Banadyga L; Zhu W; Qiu X; Guo Y
Antiviral Res; 2018 Dec; 160():87-93. PubMed ID: 30339847
[TBL] [Abstract][Full Text] [Related]
13. Macropinocytosis contributes to hantavirus entry into human airway epithelial cells.
Torriani G; Mayor J; Zimmer G; Kunz S; Rothenberger S; Engler O
Virology; 2019 May; 531():57-68. PubMed ID: 30852272
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
15. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
Herring S; Oda JM; Wagoner J; Kirchmeier D; O'Connor A; Nelson EA; Huang Q; Liang Y; DeWald LE; Johansen LM; Glass PJ; Olinger GG; Ianevski A; Aittokallio T; Paine MF; Fink SL; White JM; Polyak SJ
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468464
[TBL] [Abstract][Full Text] [Related]
17. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
Slough MM; Chandran K; Jangra RK
mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
[TBL] [Abstract][Full Text] [Related]
18. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
Zhang X; Tang K; Guo Y
Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
[TBL] [Abstract][Full Text] [Related]
19. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics.
Shrivastava-Ranjan P; Jain S; Chatterjee P; Montgomery JM; Flint M; Albariño C; Spiropoulou CF
Antiviral Res; 2023 Jun; 214():105619. PubMed ID: 37142192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
